What’s Vulnerable › Vulnerabilities

CVE-2017-17678

• Severity: medium (CVSS 6.1 v3.1)
• Exploited in the wild: not listed in CISA KEV
• EPSS: 0.6% probability of exploitation in the next 30 days
• Public exploit or detection template: none known
• Published: 2021-05-19 · updated 2026-07-09
• Weakness: CWE-79

Description

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

Affected products

• BMC Remedy Mid-Tier: 9.1-sp3

References

• https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html
• https://seclists.org/fulldisclosure/2017/Oct/52
• https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html
• https://seclists.org/fulldisclosure/2017/Oct/52

Get alerted when CVE-2017-17678 or the next vulnerability affects your stack